In preclinical tumor models, IMANs enhanced effector cell recruitment, resulting in increased tumor cell death. Additionally, they synergised with CAR-T cells to enhance tumor clearance in models of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback